These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. PYRIDOXINE-dependent epilepsy (PDE): An observational study of neonatal cases on the role of pyridoxine in patients treated with standard anti-seizure medications. Falsaperla R; Sciacca M; Collotta AD; Tardino LG; Marino S; Marino SD; Privitera GF; Vitaliti G; Ruggieri M Seizure; 2024 May; 118():156-163. PubMed ID: 38735085 [TBL] [Abstract][Full Text] [Related]
7. Clinical Reasoning: Pediatric Seizures of Unknown Cause. Tseng LA; Hoytema van Konijnenburg EMM; Longo N; Andrews A; van Wegberg A; Coene KLM; Coughlin CR; van Karnebeek CDM Neurology; 2022 Jun; 98(24):1023-1028. PubMed ID: 35470136 [TBL] [Abstract][Full Text] [Related]
8. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Gallagher RC; Van Hove JL; Scharer G; Hyland K; Plecko B; Waters PJ; Mercimek-Mahmutoglu S; Stockler-Ipsiroglu S; Salomons GS; Rosenberg EH; Struys EA; Jakobs C Ann Neurol; 2009 May; 65(5):550-6. PubMed ID: 19142996 [TBL] [Abstract][Full Text] [Related]
9. Pyridoxine-dependent epilepsy initially responsive to phenobarbital. Lin J; Lin K; Masruha MR; Vilanova LC Arq Neuropsiquiatr; 2007 Dec; 65(4A):1026-9. PubMed ID: 18094870 [TBL] [Abstract][Full Text] [Related]
10. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of pyridoxine dependent seizures in south Indian children with early onset intractable epilepsy: A hospital based prospective study. Ramachandrannair R; Parameswaran M Eur J Paediatr Neurol; 2005; 9(6):409-13. PubMed ID: 16257246 [TBL] [Abstract][Full Text] [Related]
13. Pipecolic acid as a diagnostic marker of pyridoxine-dependent epilepsy. Plecko B; Hikel C; Korenke GC; Schmitt B; Baumgartner M; Baumeister F; Jakobs C; Struys E; Erwa W; Stöckler-Ipsiroglu S Neuropediatrics; 2005 Jun; 36(3):200-5. PubMed ID: 15944906 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in pyridoxine-dependent epilepsy. Bok LA; Halbertsma FJ; Houterman S; Wevers RA; Vreeswijk C; Jakobs C; Struys E; Van Der Hoeven JH; Sival DA; Willemsen MA Dev Med Child Neurol; 2012 Sep; 54(9):849-54. PubMed ID: 22804844 [TBL] [Abstract][Full Text] [Related]
15. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy. Al Teneiji A; Bruun TU; Cordeiro D; Patel J; Inbar-Feigenberg M; Weiss S; Struys E; Mercimek-Mahmutoglu S Metab Brain Dis; 2017 Apr; 32(2):443-451. PubMed ID: 27882480 [TBL] [Abstract][Full Text] [Related]
16. Seizure recurrence following pyridoxine withdrawal in a patient with pyridoxine-dependent epilepsy. Tamaura M; Shimbo H; Iai M; Yamashita S; Osaka H Brain Dev; 2015 Apr; 37(4):442-5. PubMed ID: 25123644 [TBL] [Abstract][Full Text] [Related]
19. Pyridoxine-dependent seizures: report of a case with atypical clinical features and abnormal MRI scans. Tanaka R; Okumura M; Arima J; Yamakura S; Momoi T J Child Neurol; 1992 Jan; 7(1):24-8. PubMed ID: 1552147 [TBL] [Abstract][Full Text] [Related]
20. Pyridoxine-dependent epilepsy: an under-recognised cause of intractable seizures. Yeghiazaryan NS; Zara F; Capovilla G; Brigati G; Falsaperla R; Striano P J Paediatr Child Health; 2012 Mar; 48(3):E113-5. PubMed ID: 21496129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]